Comparing the current results to its competitors, Nutriband Inc reported Revenue decrease in the 2 quarter 2026 year on year by -29.71 %, despite the revenue increase by the most of its competitors of 18.17 %, recorded in the same quarter.
Nutriband Inc 's Comment on Competition and Industry Peers
The pharmaceutical industry is characterized by intense competition and rapid innovation, involving large pharmaceutical and biotechnology firms, specialty pharmaceutical and generic drug companies, and medical technology companies. The company’s AVERSA pipeline includes opioid-containing products such as AVERSA Fentanyl and AVERSA Buprenorphine, which will compete with existing opioid products lacking abuse deterrent features, as well as those utilizing various abuse deterrent technologies. Competition may also arise from non-opioid products or drugs not prone to abuse. Currently, the company is not aware of any abuse deterrent transdermal products either in development or on the market. Market success is not guaranteed even with regulatory approval.
April 25, 2024
Acknowledging the Essential Power of Effective Corporate Communications Strategies: Nutriband Inc. Embarks on a Strategic Alliance with IBN In the field of pharmaceuticals, the tides of innovation are ceaselessly ebbing and flowing. With the industry s incessant drive to facilitate health solutions with growing efficacy and convenience, transdermal technologies feature prominently. Herein the role of Nutriband Inc. becomes both crucial and transformative. Renowned for its unique focus on these novel technologies, Nutriband Inc., listed on NASDAQ as NTRB, is setting new milestones in pharmaceutical innovation and market presence. Adding another significant stride in its journey, Nutriband has recently announc...
Innovage Holding Corp's business model revolves around providing comprehensive managed care services to a large elderly population. Their services primarily encompass care management, coordination, and support for seniors, including provision of care plans, healthcare navigation, and home-based services. Innovage focuses on delivering personalized care and promoting independent living for seniors through their innovative healthcare programs.
Painreform Ltd operates under a business model focused on developing and commercializing innovative pharmaceutical solutions for pain management. Their approach involves creating novel drug formulations and delivery systems to improve the efficacy, safety, and patient experience in treating acute and chronic pain.
Sources:
Nutriband Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Nutriband Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
